Jump to main content
Jump to site search

Issue 6, 2016
Previous Article Next Article

Next generation sequencing: implications in personalized medicine and pharmacogenomics

Author affiliations

Abstract

A breakthrough in next generation sequencing (NGS) in the last decade provided an unprecedented opportunity to investigate genetic variations in humans and their roles in health and disease. NGS offers regional genomic sequencing such as whole exome sequencing of coding regions of all genes, as well as whole genome sequencing. RNA-seq offers sequencing of the entire transcriptome and ChIP-seq allows for sequencing the epigenetic architecture of the genome. Identifying genetic variations in individuals can be used to predict disease risk, with the potential to halt or retard disease progression. NGS can also be used to predict the response to or adverse effects of drugs or to calculate appropriate drug dosage. Such a personalized medicine also provides the possibility to treat diseases based on the genetic makeup of the patient. Here, we review the basics of NGS technologies and their application in human diseases to foster human healthcare and personalized medicine.

Graphical abstract: Next generation sequencing: implications in personalized medicine and pharmacogenomics

Back to tab navigation

Publication details

The article was received on 16 Feb 2016, accepted on 29 Mar 2016 and first published on 29 Mar 2016


Article type: Review Article
DOI: 10.1039/C6MB00115G
Citation: Mol. BioSyst., 2016,12, 1818-1830
  •   Request permissions

    Next generation sequencing: implications in personalized medicine and pharmacogenomics

    B. Rabbani, H. Nakaoka, S. Akhondzadeh, M. Tekin and N. Mahdieh, Mol. BioSyst., 2016, 12, 1818
    DOI: 10.1039/C6MB00115G

Search articles by author

Spotlight

Advertisements